A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)

Clinical trial NCT07545759 · RECRUITING

Trial details

NCT number: NCT07545759
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome Diarrhea

Start date: 2026-05-06
Primary completion: 2027-09-01
Enrollment: 531

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.